Carol Massar and Tim Stenovec bring together the latest news from the world of business and finance and the interesting stories of global technology, politics, economics and more by harnessing the power of Bloomberg Businessweek reporters and editor
Bloomberg Businessweek: NYC Congestion Pricing, Stem Cell Therapy
Bloomberg Businessweek
NYC Congestion Pricing, Stem Cell Therapy
Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF. Journalist and author Henry Grabar on NYC’s Congestion Pricing and how this could help the Democratic Party. Dr. Silviu Itescu, CEO at Mesoblast, on MESO stock soaring after FDA stem cell therapy approval. Discussing MESO stock soaring on stem cell therapy approval by the FDA. And we Drive to the Close with Tony Roth CIO at Wilmington Trust Hosts:Carol Massar and Tim Stenovec. Producer: Paul Brennan and Sebastian Escobar
Jan 06, 2025